Among them, the most significant transcription factors potentially dysregulated in MS are YY1 (yin and yang 1), E2F-1/DP-1 and E2F-4/DP-2 heterodimers, EGR family members and CREB and ATF families. This evidence concerns the gene E2F1 and myeloid sarcoma.